Pfizer announced on Friday that it will stop pursuing the twice-daily version of its experimental weight loss pill after obese patients in a mid-stage clinical study reported significant weight loss but had difficulty tolerating the drug due to high rates of mild and gastrointestinal side effects. The pharmaceutical giant’s decision comes after it observed that…
Eli Lilly’s stock saw a significant increase on Wednesday after the U.S. government approved the company’s GLP-1 drug for obesity treatment. The FDA’s decision was no surprise, and now Eli Lilly is gearing up to market the drug as Zepbound. The stock price soared by almost 2% in response to the news, reaching $611.36 per…
French prosecutors have launched a preliminary investigation into multinational pharmaceutical company Sanofi over potential market manipulation. The Parquet National Financier, the French financial prosecutor, opened the probe in March 2023, focusing on allegations of “dissemination of false or misleading information and price manipulation” related to Sanofi’s past financial communications. Sanofi has responded by stating that…
Deeply divided Republican lawmakers are currently facing a leadership crisis in the House of Representatives as they try to select a nominee for speaker for the third time. After two previous candidates failed to garner enough support within the party, Republicans held a closed-door candidate forum on Monday evening with nine lawmakers vying for the…
Johnson & Johnson (J&J) reported adjusted earnings and revenue on Tuesday that exceeded Wall Street’s expectations, leading the company to raise its full-year guidance. This comes after J&J completed its separation from consumer health spinoff Kenvue in August, marking the largest shake-up in the company’s history. After the split, J&J initially lowered its full-year sales…
